CIA
TEVA icon

Choate Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Choate Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,525
Closed -$316K – 250
2017
Q2 		$316K Sell
9,525
-15,712
-62% -$486K 0.02% 201
2017
Q1 		$810K Sell
25,237
-11,768
-32% -$402K 0.05% 132
2016
Q4 		$1.34M Sell
37,005
-3,045
-8% -$122K 0.09% 93
2016
Q3 		$1.84M Sell
40,050
-1,022
-2% -$53.3K 0.12% 81
2016
Q2 		$2.06M Sell
41,072
-2,638
-6% -$140K 0.14% 76
2016
Q1 		$2.34M Sell
43,710
-4,654
-10% -$273K 0.16% 71
2015
Q4 		$2.78M Buy
48,364
+1,504
+3% +$92.9K 0.2% 68
2015
Q3 		$2.65M Sell
46,860
-999
-2% -$64.8K 0.18% 63
2015
Q2 		$2.83M Sell
47,859
-655
-1% -$40.4K 0.16% 61
2015
Q1 		$3.02M Buy
48,514
+150
+0.3% +$8.72K 0.17% 62
2014
Q4 		$2.78M Sell
48,364
-7,903
-14% -$440K 0.16% 70
2014
Q3 		$3.02M Sell
56,267
-5,492
-9% -$291K 0.18% 61
2014
Q2 		$3.24M Buy
61,759
+6,936
+13% +$355K 0.19% 62
2014
Q1 		$2.9M Sell
54,823
-1,890
-3% -$87.4K 0.18% 64
2013
Q4 		$2.27M Sell
56,713
-5,175
-8% -$204K 0.15% 81
2013
Q3 		$2.34M Sell
61,888
-1,719
-3% -$67.1K 0.17% 78
2013
Q2 		$2.49M Buy
+63,607
New +$2.48M 0.2% 72

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Choate Investment Advisors's TEVA Position: Q3 2017 in Review

Choate Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 9,525 shares — an estimated $316K sold.

Choate Investment Advisors first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $3.24M in Q2 2014. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Choate Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Choate Investment Advisors sold 9,525 Teva Pharmaceuticals shares in Q3 2017, an estimated $316K.
  • Choate Investment Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Choate Investment Advisors's Teva Pharmaceuticals position peaked at $3.24M in Q2 2014.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Choate Investment Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.